
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $100.8M | -- | -- | $0.79 | -- |
07/24/2025 | Q2 | $99.2M | -- | -- | $0.81 | -- |
04/24/2025 | Q1 | $96.4M | $93.8M | $0.87 | $0.75 | $0.12 |
01/30/2025 | Q4 | $96.9M | $94.3M | $0.86 | $0.77 | $0.09 |
10/17/2024 | Q3 | $99.1M | $96.4M | $0.85 | $0.81 | $0.04 |
07/18/2024 | Q2 | $96.3M | $96.9M | $0.89 | $0.74 | $0.15 |
04/18/2024 | Q1 | $98M | $96.3M | $0.81 | $0.78 | $0.03 |
01/25/2024 | Q4 | $99.8M | $103.2M | $0.96 | $0.86 | $0.10 |
10/19/2023 | Q3 | -- | -- | $0.87 | $0.91 | -$0.04 |
07/20/2023 | Q2 | -- | -- | $0.89 | $0.89 | -$0.00 |
04/20/2023 | Q1 | -- | -- | $1.02 | $0.94 | $0.08 |
01/26/2023 | Q4 | -- | -- | $1.03 | $0.94 | $0.09 |
10/20/2022 | Q3 | -- | -- | $0.95 | $0.83 | $0.12 |
07/21/2022 | Q2 | -- | -- | $0.74 | $0.66 | $0.08 |
04/21/2022 | Q1 | -- | -- | $0.74 | $0.58 | $0.16 |
01/27/2022 | Q4 | -- | -- | $0.57 | $0.63 | -$0.06 |
10/21/2021 | Q3 | -- | -- | $0.70 | $0.61 | $0.09 |
07/22/2021 | Q2 | -- | -- | $0.72 | $0.68 | $0.04 |
04/22/2021 | Q1 | -- | -- | $0.81 | $0.64 | $0.17 |
01/28/2021 | Q4 | -- | -- | $0.62 | $0.51 | $0.11 |
10/22/2020 | Q3 | -- | -- | $0.43 | $0.43 | -$0.00 |
07/30/2020 | Q2 | -- | -- | -$0.85 | $0.30 | -$1.15 |
04/30/2020 | Q1 | -- | -- | $0.34 | $0.51 | -$0.17 |
01/30/2020 | Q4 | -- | -- | $0.56 | $0.77 | -$0.20 |
10/24/2019 | Q3 | -- | -- | $0.79 | $0.77 | $0.02 |
07/18/2019 | Q2 | -- | -- | $0.78 | $0.75 | $0.03 |
04/18/2019 | Q1 | -- | -- | $0.66 | $0.74 | -$0.08 |
01/31/2019 | Q4 | -- | -- | $0.77 | $0.78 | -$0.01 |
10/18/2018 | Q3 | -- | -- | $0.80 | $0.76 | $0.04 |
07/19/2018 | Q2 | -- | -- | $0.61 | $0.61 | $0.00 |
04/19/2018 | Q1 | -- | -- | $0.70 | $0.69 | $0.01 |
01/25/2018 | Q4 | -- | -- | $0.65 | $0.62 | $0.03 |
10/19/2017 | Q3 | -- | -- | $0.65 | $0.60 | $0.05 |
07/20/2017 | Q2 | -- | -- | $0.58 | $0.57 | $0.01 |
04/20/2017 | Q1 | -- | -- | -- | $0.53 | -- |
01/26/2017 | Q4 | -- | -- | $0.51 | $0.54 | -$0.03 |
10/20/2016 | Q3 | -- | -- | $0.59 | $0.50 | $0.09 |
07/21/2016 | Q2 | -- | -- | $0.49 | $0.50 | -$0.01 |
04/21/2016 | Q1 | -- | -- | $0.46 | $0.53 | -$0.07 |
01/26/2016 | Q4 | -- | -- | $0.50 | $0.54 | -$0.04 |
10/20/2015 | Q3 | -- | -- | $0.54 | $0.56 | -$0.02 |
S&T Bancorp reported $93.8M worth of top line sales in its most recent quarter.
S&T Bancorp announced earnings per share of $0.87 which represents a beat of analyst forecast a $0.75 per share.
S&T Bancorp reported -- that represents -- per share over the last quarter.
S&T Bancorp's earnings are forecast to decrease from $3.41 per share to $3.36 per share next year representing a decrease of -3.93%.
S&T Bancorp's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.